Half the dose of antipsychotic in case of extrapyramidal symptoms [4]

Schizophrenia Research

Volumn 78, Issue 2-3, 2005, Pages 347-349

  Tort, Adriano B L ^a   Souza, Diogo O ^a   Lara, Diogo R ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LETTER; MATHEMATICAL MODEL; PRIORITY JOURNAL;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, BIOLOGICAL; PSYCHOTIC DISORDERS;

EID: 24344507210     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2005.05.026     Document Type: Letter

References (4)

1. L. Farde, A.L. Nordstrom, F.A. Wiesel, S. Pauli, C. Halldin, and G. Sedvall Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects Arch. Gen. Psychiatry 49 1992 538 544
2. S. Kapur, and D. Mamo Half a century of antipsychotics and still a central role for dopamine D2 receptors Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 1081 1090
3. S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia Am. J. Psychiatry 157 2000 514 520
4. A.L. Nordstrom, L. Farde, F.A. Wiesel, K. Forslund, S. Pauli, C. Halldin, and G. Uppfeldt Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients Biol. Psychiatry 33 1993 227 235